Amplified CD137 molecules are loaded on surface of T cell membrane, binding with CD137 ligands (CD137L) and promote T cell proliferation, anti-apoptosis, cytokine secretion, chromatin remodeling, and mitochondrial fitness [43], inducing tumor regression in various mouse models [44–46]. The gene discussed is TNFRSF9; the disease is neoplasm.